FDA
The FDA made its case before the U.S. Court of Appeals for the DC Circuit, seeking to overturn a previous ruling that exempted premium cigars from regulation. Despite its efforts,...
Published September 2024
The U.S. Court of Appeals for the District of Columbia has outlined the procedural timeline for the next phase of the protracted legal battle between the Cigar Association of America...
Published December 2023
As the cigar industry awaits a federal appeals court decision on the FDA’s regulation of “premium cigars,” a new resolution has emerged in the U.S. House of Representatives seeking to...
Published December 2023
The U.S. Food & Drug Administration (FDA) has introduced revised penalties for violations of federal laws governing tobacco products in the country, marking an adjustment in accordance with the Federal...
Published November 2023
The Premium Cigar Association (PCA) testified before the White House Office of Management and Budget’s Office of Information and Regulatory Affairs (OIRA) as part of the Administration’s review of the...
Published November 2023